Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME-Reference-Cited by-同舟云学术

Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME

Published:2020-03-28 Issue:7 Volume:22 Page:1207-1214
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Verma Subodh¹^ORCID,Ji Qiuhe²^ORCID,Bhatt Deepak L.³,Mazer C. David⁴,Al‐Omran Mohammed⁵,Inzucchi Silvio E.⁶,Wanner Christoph⁷,Ofstad Anne Pernille⁸^ORCID,Zwiener Isabella⁹,George Jyothis T.¹⁰,Zinman Bernard¹¹^ORCID,Fitchett David¹²^ORCID

Affiliation:

1. St Michael's Hospital, Division of Cardiac SurgeryUniversity of Toronto Toronto Ontario Canada

2. Xijing HospitalFourth Military Medical University, Xi'an China

3. Brigham and Women's Hospital Heart and Vascular Centre and Harvard Medical School Boston Massachusetts USA

4. St Michael's Hospital, Department of AnaesthesiaUniversity of Toronto Toronto Ontario Canada

5. St Michael's Hospital, Division of Vascular SurgeryUniversity of Toronto Toronto Ontario Canada

6. Yale University School of Medicine New Haven Connecticut USA

7. Würzburg University Clinic Würzburg Germany

8. Boehringer Ingelheim Norway KS, Asker Norway

9. Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim Germany

10. Boehringer Ingelheim International GmbH, Ingelheim Germany

11. Lunenfeld‐Tanenbaum Research Institute, Mount Sinai HospitalUniversity of Toronto Toronto Ontario Canada

12. St Michael's Hospital, Division of CardiologyUniversity of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13991

Reference11 articles.

1. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

2. Uric acid and cardiovascular disease

3. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation

4. Uric acid and the cardio‐renal effects of SGLT2 inhibitors

5. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-07-12

2. Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2024-05-12

3. The association between variability of risk factors and complications in type 2 diabetes mellitus: a retrospective study;Scientific Reports;2024-03-16

4. Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and Heart Failure;Journal of the American College of Cardiology;2024-01

5. Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications;Biomedicine & Pharmacotherapy;2023-12